Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionBeech Hill Advisors, Inc.
Latest Disclosed Ownership8,390 shares
Latest Disclosed Value $ 1,169,314
Beech Hill Advisors, Inc. reports 11.57% decrease in ownership of GILD / Gilead Sciences, Inc.

On April 9, 2026 - Beech Hill Advisors, Inc. filed a 13F-HR form disclosing ownership of 8,390 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,169,314 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 14, 2026 disclosing 9,488 shares of Gilead Sciences, Inc.. This represents a change in shares of -11.57% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-09 2026-03-31 13F GILEAD SCIENCES COM 375558103 8,390 -1,098 -11.57 1,169 0.43 0.5857
2026-01-14 2025-12-31 13F GILEAD SCIENCES COM 375558103 9,488 -390 -3.95 1,165 6.20 0.5574
2025-10-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 9,878 -1,155 -10.47 1,096 -10.38 0.5121
2025-07-30 2025-06-30 13F GILEAD SCIENCES COM 375558103 11,033 -3,155 -22.24 1,223 -23.03 0.5505
2025-04-23 2025-03-31 13F GILEAD SCIENCES COM 375558103 14,188 -55 -0.39 1,590 20.84 0.6327
2025-01-15 2024-12-31 13F GILEAD SCIENCES COM 375558103 14,243 -345 -2.36 1,316 7.52 0.4924
2024-10-16 2024-09-30 13F GILEAD SCIENCES COM 375558103 14,588 226 1.57 1,223 24.16 0.4637
2024-07-12 2024-06-30 13F GILEAD SCIENCES COM 375558103 14,362 -685 -4.55 985 -10.62 0.4066
2024-04-12 2024-03-31 13F GILEAD SCIENCES COM 375558103 15,047 585 4.05 1,102 -5.89 0.4580
2024-01-10 2023-12-31 13F GILEAD SCIENCES COM 375558103 14,462 60 0.42 1,172 8.53 0.5667
2023-10-11 2023-09-30 13F GILEAD SCIENCES COM 375558103 14,402 197 1.39 1,079 -1.37 0.5442
2023-07-11 2023-06-30 13F GILEAD SCIENCES COM 375558103 14,205 2,000 16.39 1,095 8.10 0.5322
2023-04-14 2023-03-31 13F GILEAD SCIENCES COM 375558103 12,205 -560 -4.39 1,013 -7.58 0.5101
2023-01-18 2022-12-31 13F GILEAD SCIENCES COM 375558103 12,765 0 0.00 1,096 39.14 0.6091
2022-10-12 2022-09-30 13F GILEAD SCIENCES COM 375558103 12,765 180 1.43 787 1.16 0.4509
2022-07-11 2022-06-30 13F GILEAD SCIENCES COM 375558103 12,585 825 7.02 778 11.30 0.4156
2022-04-19 2022-03-31 13F GILEAD SCIENCES COM 375558103 11,760 940 8.69 699 -11.07 0.2852
2022-01-19 2021-12-31 13F GILEAD SCIENCES COM 375558103 10,820 10,820 786 0.2986
2020-05-05 2020-03-31 13F GILEAD SCIENCES COM 375558103 0 -8,725 -100.00 0 -100.00
2020-01-17 2019-12-31 13F GILEAD SCIENCES COM 375558103 8,725 -175 -1.97 567 0.53 0.2642
2019-10-18 2019-09-30 13F GILEAD SCIENCES COM 375558103 8,900 0 0.00 564 -6.16 0.3013
2019-07-15 2019-06-30 13F GILEAD SCIENCES COM 375558103 8,900 0 0.00 601 3.80 0.3155
2019-04-09 2019-03-31 13F GILEAD SCIENCES COM 375558103 8,900 1,350 17.88 579 22.67 0.3572
2019-01-14 2018-12-31 13F GILEAD SCIENCES COM 375558103 7,550 0 0.00 472 -19.04 0.2936
2018-10-10 2018-09-30 13F GILEAD SCIENCES COM 375558103 7,550 0 0.00 583 8.97 0.3023
2018-08-01 2018-06-30 13F GILEAD SCIENCES COM 375558103 7,550 575 8.24 535 1.71 0.2996
2018-04-23 2018-03-31 13F GILEAD SCIENCES COM 375558103 6,975 -4,000 -36.45 526 -33.08 0.2768
2018-01-22 2017-12-31 13F GILEAD SCIENCES COM 375558103 10,975 500 4.77 786 -7.42 0.3881
2017-10-20 2017-09-30 13F GILEAD SCIENCES COM 375558103 10,475 3,600 52.36 849 74.33 0.4478
2017-07-18 2017-06-30 13F GILEAD SCIENCES COM 375558103 6,875 -66,550 -90.64 487 -90.23 0.2662
2017-04-19 2017-03-31 13F GILEAD SCIENCES COM 375558103 73,425 31,195 73.87 4,987 64.91 2.8690
2017-01-25 2016-12-31 13F GILEAD SCIENCES COM 375558103 42,230 3,450 8.90 3,024 -1.43 1.8081
2016-10-21 2016-09-30 13F GILEAD SCIENCES COM 375558103 38,780 38,780 0.00 3,068 1.8770
2016-04-20 2016-03-31 13F GILEAD SCIENCES COM 375558103 0 -36,815 -100.00 0 -100.00
2016-01-26 2015-12-31 13F GILEAD SCIENCES COM 375558103 36,815 -4,350 -10.57 3,725 -7.84 2.3554
2015-10-30 2015-09-30 13F GILEAD SCIENCES COM 375558103 41,165 -758 -1.81 4,042 -17.64 2.5748
2015-08-12 2015-06-30 13F GILEAD SCIENCES COM 375558103 41,923 -20,529 -32.87 4,908 -19.91 2.5233
2015-04-29 2015-03-31 13F GILEAD SCIENCES COM 375558103 62,452 62,452 0.00 6,128 2.8799
2015-01-30 2014-12-31 13F GILEAD SCIENCES COM 375558103 0 -53,100 -100.00 0 -100.00
2014-10-21 2014-09-30 13F GILEAD SCIENCES COM 375558103 53,100 -1,355 -2.49 5,652 25.18 2.6730
2014-07-21 2014-06-30 13F GILEAD SCIENCES COM 375558103 54,455 54,455 4,515 1.9888
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.